SCHEMBL23937896

SCHEMBL23937896

COn1cc(C(F)(F)F)c2c1CCCC2

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.32
HSD17B10 Q99714 2/20 0.32
LMNA P02545 2/20 0.32
TSHR P16473 2/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
CYP1A2 P05177 2/20 0.31
GRIA2 P42262 2/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2D6 P10635 1/20 0.31
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23937904 0.71 LMNA (0.36) HSD17B10LMNATSHRGAAKDM4E
SCHEMBL20631118 0.69 CA2 (0.32) HSD17B10LMNATSHRGAAKDM4E
SCHEMBL23937916 0.66 HSD17B10 (0.37) SMN1; SMN2HSD17B10TSHRMAPTKDM4E
SCHEMBL21957120 0.62 AR (0.41) MEN1KMT2A
SCHEMBL23937832 0.60 GRM2 (0.32)
SCHEMBL19531765 0.59 ALDH1A1 (0.30) SMN1; SMN2LMNAALDH1A1
SCHEMBL20756625 0.57 HTR2A (0.62) HTR2AHSD17B10LMNAALDH1A1HPGD
SCHEMBL20631714 0.55 GRM2 (0.32)
SCHEMBL14401055 0.55 LMNA (0.55) SMN1; SMN2LMNATSHRGAAMAPT
SCHEMBL14198837 0.54 HTR2A (0.49) HTR2AHSD17B10LMNAGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3399968-B1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS PHARMATECH LTD (KY) 2021-10-20 EP disclosed